BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. The Company's product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus.

Share

Connect with us

.dark-mode .htkflm{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .htkflm{ color: #333333; background-color: white; border: 2px solid #333333; }BLUCTBellus Health Incstock TSE

BLUCT
Bellus Health Inc
stock TSE